Trial Profile
Gemcitabine versus cisplatin chemoradiotherapy in locally advanced head and neck cancer
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 21 Jul 2014
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Cisplatin
- Indications Head and neck cancer; Squamous cell cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Jul 2014 New trial record
- 03 Jun 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.